Author

Rohit Verma

Translational Health Science and Technology Institute

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Baibaswata NayakiD· 1 shared Dipanka Tanu Sarmah· 1 shared Kannan ChandrasekariD· 1 shared Milan SurjitiD· 1 shared S. ShalimariD· 1 shared Samrat ChatterjeeiD· 1 shared Shabnam AnsariiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Baibaswata NayakORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Network controllability analysis reveals the antiviral potential of Etravirine against Hepatitis E Virus infection

Shabnam Ansari, Dipanka Tanu Sarmah, Rohit Verma, Kannan Chandrasekar, S. Shalimar, Baibaswata Nayak, Samrat Chatterjee, Milan Surjit

This study identifies CK1ε as an antiviral target for HEV and shows that Etravirine, an HIV drug, inhibits CK1ε to exhibit antiviral activity against HEV.

mSystems · Aug 15, 2025Peer-reviewedMicrobiology